Option Care Health (NASDAQ:OPCH) Issues Earnings Results

Option Care Health (NASDAQ:OPCH) released its earnings results on Tuesday. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.04, Briefing.com reports. The company had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.10 billion. Option Care Health had a net margin of 6.21% and a return on equity of 18.78%. The firm’s quarterly revenue was up 12.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.21 EPS. Option Care Health updated its FY 2024 guidance to EPS.

Option Care Health Stock Performance

Shares of Option Care Health stock traded down $0.54 on Wednesday, reaching $30.05. 588,235 shares of the company were exchanged, compared to its average volume of 1,249,972. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77. The company’s 50-day moving average is $32.19 and its two-hundred day moving average is $31.53. The firm has a market cap of $5.22 billion, a price-to-earnings ratio of 20.29, a P/E/G ratio of 1.73 and a beta of 1.22. Option Care Health has a 1-year low of $24.23 and a 1-year high of $35.74.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. Jefferies Financial Group raised their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a report on Monday, March 4th. Barrington Research raised their price objective on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “outperform” rating in a research report on Friday, February 23rd.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the firm’s stock in a transaction on Monday, February 26th. The stock was purchased at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the purchase, the director now owns 269,528 shares in the company, valued at approximately $8,503,608.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.